Longitudinal Health-related Quality of Life among Individuals Considering Treatment for Stage I Non–Small-Cell Lung Cancer
- 1 August 2020
- journal article
- research article
- Published by American Thoracic Society in Annals of the American Thoracic Society
- Vol. 17 (8), 988-997
- https://doi.org/10.1513/annalsats.202001-029oc
Abstract
Rationale: Due to improvements in screening, there is an increasing number of patients with early stage non-small cell lung cancer who are making treatment decisions. Objectives: Among patients with suspected stage I non-small cell lung cancer (NSCLC), we evaluated longitudinal patient-centered outcomes (PCOs) and the association of changes in PCOs with treatment modality, stereotactic body radiotherapy (SBRT) compared to surgical resection. Methods: We conducted a multi-site, prospective, observational cohort study at seven medical institutions. We evaluated minimum clinically important differences (MCID) of PCOs at four time points (during treatment, 4-6 weeks post-treatment, 6-months post-treatment, and 12-months post-treatment) compared to pre-treatment values using validated instruments. We used adjusted linear mixed models to examine whether the association between treatment and European Organization for Research and Treatment of Cancer global and physical quality of life (QOL) scales differed over time. Results: We included 127 individuals with stage I NSCLC (53 surgery, 74 SBRT). At 12-months, approximately 30% of patients remaining in each group demonstrated a clinical deterioration on global QOL from baseline. There was a significant difference in slopes between treatment groups on global QOL (-12.86, 95% CI = -13.34, -12.37) and physical QOL (-28.71, 95% CI = -29.13, -28.29) between baseline and during treatment, with the steeper decline observed among those who underwent surgery. Differences in slopes between treatment groups were not significant at all other time points. Conclusions: Approximately 30% of patients with stage I NSCLC have a clinically significant decrease in QOL one year after SBRT or surgical resection. Surgical resection was associated with steeper declines in QOL immediately after treatment compared to SBRT, however, these declines were not lasting and resolved within a year for most patients. Our results may facilitate treatment option discussions for patients receiving treatment for early stage NSCLC.Keywords
This publication has 28 references indexed in Scilit:
- Screening for Lung Cancer With Low-Dose Computed Tomography: A Systematic Review to Update the U.S. Preventive Services Task Force RecommendationAnnals of Internal Medicine, 2013
- Health-related quality of life after surgical treatment in patients with non-small cell lung cancer: A systematic reviewLung Cancer, 2013
- Physiologic Evaluation of the Patient With Lung Cancer Being Considered for Resectional SurgerySocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2013
- Treatment of Stage I and II Non-small Cell Lung CancerSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2013
- Quality of Life and Survival in the 2 Years After Surgery for Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2008
- Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials GroupEuropean Journal of Cancer, 2005
- What is a clinically meaningful change on the Functional Assessment of Cancer Therapy–Lung (FACT-L) Questionnaire?: Results from Eastern Cooperative Oncology Group (ECOG) Study 5592Journal of Clinical Epidemiology, 2002
- The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30Quality of Life Research, 1996
- The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trialsEuropean Journal of Cancer, 1994
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993